MX2017015068A - Combination and composition for the treatment of disorders of the arterial circulatory system. - Google Patents
Combination and composition for the treatment of disorders of the arterial circulatory system.Info
- Publication number
- MX2017015068A MX2017015068A MX2017015068A MX2017015068A MX2017015068A MX 2017015068 A MX2017015068 A MX 2017015068A MX 2017015068 A MX2017015068 A MX 2017015068A MX 2017015068 A MX2017015068 A MX 2017015068A MX 2017015068 A MX2017015068 A MX 2017015068A
- Authority
- MX
- Mexico
- Prior art keywords
- disorders
- treatment
- composition
- combination
- circulatory system
- Prior art date
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 208000035475 disorder Diseases 0.000 title 1
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 230000001413 cellular effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000001804 emulsifying effect Effects 0.000 abstract 1
- 230000002503 metabolic effect Effects 0.000 abstract 1
- 235000013406 prebiotics Nutrition 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to the pharmaceutical field comprising a nitric oxide liberator, a prebiotic substance, an emulsifying substance, a metabolic agent to increase the production of cellular energy and acceptable carrier vehicles. The formula is related to indications to carry out the manufacture of a drug whose function has benefits in patients with circulatory diseases.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2017015068A MX2017015068A (en) | 2017-11-14 | 2017-11-14 | Combination and composition for the treatment of disorders of the arterial circulatory system. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2017015068A MX2017015068A (en) | 2017-11-14 | 2017-11-14 | Combination and composition for the treatment of disorders of the arterial circulatory system. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2017015068A true MX2017015068A (en) | 2019-05-15 |
Family
ID=67298977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017015068A MX2017015068A (en) | 2017-11-14 | 2017-11-14 | Combination and composition for the treatment of disorders of the arterial circulatory system. |
Country Status (1)
| Country | Link |
|---|---|
| MX (1) | MX2017015068A (en) |
-
2017
- 2017-11-14 MX MX2017015068A patent/MX2017015068A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201907684PA (en) | Androgen receptor modulator and uses thereof | |
| SG10201808102WA (en) | Bicyclic heterocycle compounds and their uses in therapy | |
| NZ720736A (en) | Antibody drug conjugates (adcs) with kinesin spindel protein (ksp) | |
| MY184292A (en) | Substituted aminopyrimidine compounds and methods of use | |
| UA109991C2 (en) | CARBAMATE COMPOUNDS, THEIR PREPARATION AND APPLICATION | |
| PH12015500274B1 (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diseases | |
| MX373851B (en) | METHODS OF ADMINISTRATION OF PIRFENIDONE TREATMENT. | |
| MY181828A (en) | Bicyclically substituted uracils and the use therapy | |
| PH12015500713A1 (en) | Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases | |
| MX2019005300A (en) | POLYMERS LINKED TO PROTON FOR ORAL ADMINISTRATION. | |
| SG10201805267UA (en) | Piperazine derivatives having multimodal activity against pain | |
| MX340985B (en) | N-heteroaryl compounds. | |
| MX373231B (en) | ANTICANCER AGENT. | |
| EP4606430A3 (en) | Use of il-22 dimer in manufacture of a medicament for intravenous administration | |
| BR112017023170A2 (en) | medicinal bath device and its use | |
| PH12016502352A1 (en) | Pharmaceutical composition | |
| NZ702242A (en) | Agent for prophylactic and/or therapeutic treatment of peripheral neuropathic pain caused by anticancer agent | |
| TN2019000083A1 (en) | 7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof | |
| PH12015502203A1 (en) | Phenyl derivative | |
| TW201613599A (en) | Use of composition for manufacture of medicament for suppressing androgen receptor related function and treatment of androgen receptor related disease | |
| MX2017015068A (en) | Combination and composition for the treatment of disorders of the arterial circulatory system. | |
| MX2018011607A (en) | Sultiame for the treatment of sleep apnea. | |
| WO2015069656A8 (en) | Methods of reducing doses of erythropoietin stimulating agents in hyporesponsive patients | |
| EA201691562A2 (en) | FILTERS FOR INFUSION KITS | |
| UA90706U (en) | Method for medicamentous correction of the impaired production of nitric oxide in treating diabetic nephropathy |